Effects of Customized Insoles for Individuals With Symptomatic Hallux Valgus
Hallux Valgus, Foot Diseases, Foot Deformities
About this trial
This is an interventional treatment trial for Hallux Valgus focused on measuring hallux valgus, insoles, pain
Eligibility Criteria
Inclusion Criteria:
- Individuals of both sexes aged over 18 years;
- Presence of mild to moderate hallux valgus, according to the Manchester scale;
- Presenting no hallux with intensity greater than or equal to 3 points up to 8 points, according to the Numerical Pain Scale (END);
- Be available to actively use the insole for at least 4 hours/day;
- Commitment to wear closed shoes, for example (sneakers, shoes used by the patient, due to: wide toe cap and heel height of 2 to 3 cm) during the study.
Exclusion Criteria:
- Being in physical therapy treatment for hallux valgus concomitantly with the research;
- Previous hallux valgus surgeries performed in the last 5 years;
- Presence of foot wounds and wounds, dislocations or metatarsophalangeal fractures in the foot with HV, in the last 5 years
- Presence of diseases such as rheumatoid arthritis, decompensated diabetes, gout, neurodegenerative diseases;
- Cognitive and mental disorder being unable to respond; those related to the study
Sites / Locations
- Marcelo Cardoso de Souza
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Customized insoles group
Sham Insoles Group
The participant allocated in the CIG will receive a semi-flexible non-moulded insole with a 2.5mm coverage with Shore A 28, a 5mm retrocapital bar with a Shore A 22 and a 2mm infracapital bar of the first metatarsal with a Shore A 35, produced in acetate. -ethylene vinyl (EVA) and manufactured by researcher C. The insole will be used on both feet to maintain symmetry between the limbs and generate greater comfort, since this will not be a corrective intervention.
The SIG will receive the same unmolded insole with a semi-flexible base and 2.5mm coverage with Shore A 28, but without the bars used in the intervention group.